Do you provide Phase I/II enzyme induction?
Phase I and phase II enzymes under cosmetic treatment
This service tests whether an ingredient changes the expression or the activity of selected biotransformation enzymes. Keratinocytes, reconstructed epidermis or skin explants are treated with the ingredient, then challenged with a model pollutant such as benzo[a]pyrene, and enzyme levels are compared with untreated controls.
Phase I oxidative enzymes
Skin-cell models support work on cytochrome P450 enzymes, including CYP1A1 and CYP1B1 where relevant. These enzymes transform organic compounds through reactions such as oxidation. EROD activity is a common readout for CYP1A1. Some transformations lower toxicity and some produce reactive intermediates, so the assay reads activity against stress markers.
- Expression changes after treatment
- Activity measured with suitable enzyme substrates
- Responses during a defined xenobiotic challenge
- Viability and oxidative-stress markers
Phase II conjugation pathways
Studies may measure glutathione S-transferase, UDP-glucuronosyltransferase or relevant sulfation routes. Conjugation can change a compound’s solubility and disposition. NQO1 and heme oxygenase-1 are often added as markers of the NRF2-driven response. Results are given as fold change against vehicle, with statistics for each concentration. The report separates enzyme abundance from measured catalytic activity and compares treated samples with matched controls.
When the question moves from induction to the fate of the compound itself, phase-I/II biotransformation tracks the parent and its metabolites. You receive data naming the enzymes, the substrates, the challenge and the direction of each response, ready to feed an anti-pollution mechanism file.
Using phase I/II induction data
Phase I/II induction data support anti-pollution claims that describe the skin’s own defence enzymes. Ingredient suppliers use the same data in technical sheets for anti-pollution actives.
Investigate biotransformation capacity
CYP1A1 or CYP1B1 expression and activity can be read with a defined substrate or challenge, alongside phase II conjugation endpoints. Read phase I and phase II results together: a profile that raises conjugation enzymes alongside CYP activity shows the cell can clear the intermediates it forms. Where the trigger is receptor-driven, AHR pathway modulation explains the upstream signal.
Test the functional consequence
Metabolite and damage endpoints show whether an altered enzyme response travels with less injury in the model. Choose the challenge compound to match the pollutant in your claim, for example a polycyclic aromatic hydrocarbon for traffic and smoke exposure. Ask the laboratory to report the compound, the model and the reaction measured, so the result can be cited as mechanistic evidence in your claim file. Tell the provider the use concentration of your ingredient, so the tested doses bracket it.
More in Xenobiotic & Cellular Clearance Studies
Xenobiotic & Cellular Clearance Studies show how skin cells respond to pollutants and foreign compounds, and how an active supports their recycling system.










